Table 2.
Categories of total coffee intake
|
p-trend | ||||||
---|---|---|---|---|---|---|---|
None | < 1 cup/day | 1cup/day | 2–3 cups/day | 4–5 cups/day | ≤6 cups/day | ||
Total prostate cancer | |||||||
n=23,335 | 2,136 | 3,894 | 3,781 | 9,835 | 2,902 | 787 | |
Age-adjusted HR | 1.00 | 1.01 (0.96, 1.07) | 0.96 (0.91, 1.01) | 0.94 (0.89, 0.98) | 0.91 (0.86, 0.96) | 0.82 (0.76, 0.89) | <0.0001 |
Multivariate-adjusted HR | 1.00 | 1.03 (0.98, 1.08) | 1.00 (0.95, 1.06) | 1.00 (0.96, 1.05) | 1.00 (0.94, 1.06) | 0.94 (0.87, 1.02) | 0.08 |
Fatal prostate cancer | |||||||
n=917 | 87 | 144 | 139 | 400 | 110 | 37 | |
Age-adjusted HR | 1.00 | 0.89 (0.69, 1.17) | 0.81 (0.62, 1.06) | 0.90 (0.72, 1.14) | 0.86 (0.65, 1.14) | 1.02 (0.69, 1.49) | 0.87 |
Multivariate-adjusted HR | 1.00 | 0.89 (0.68, 1.16) | 0.81 (0.62, 1.06) | 0.87 (0.69, 1.11) | 0.77 (0.58, 1.03) | 0.80 (0.53, 1.18) | 0.20 |
Advanced prostate cancer | |||||||
n= 2,927 | 264 | 510 | 440 | 1,185 | 401 | 127 | |
Age-adjusted HR | 1.00 | 1.09 (0.94, 1.26) | 0.93 (0.80, 1.08) | 0.92 (0.81, 1.06) | 1.01 (0.86,1.17) | 1.04(0.84, 1.29) | 0.56 |
Multivariate-adjusted HR | 1.00 | 1.10 (0.95, 1.28) | 0.97 (0.83, 1.14) | 0.98 (0.86, 1.12) | 1.08 (0.92, 1.27) | 1.15 (0.92, 1.43) | 0.62 |
Nonadvanced prostate cancer | |||||||
n=18,993 | 1,744 | 3,168 | 3,097 | 8,048 | 2,325 | 611 | |
Age-adjusted HR | 1.00 | 1.01 (0.95, 1.07) | 0.96 (0.90, 1.02) | 0.94 (0.89, 0.99) | 0.89 (0.84, 0.95) | 0.78 (0.72, 0.86) | <0.0001 |
Multivariate-adjusted HR | 1.00 | 1.03 (0.97, 1.09) | 1.01 (0.95, 1.07) | 1.01 (0.96, 1.07) | 0.99 (0.93, 1.06) | 0.92 (0.84, 1.01) | 0.07 |
The multivariate models are adjusted for age, race, height, BMI, physical activity, smoking, history of diabetes, family history of prostate cancer, PSA testing, intakes of tomato sauce, alpha-linolenic acid and total energy intake.
Cases with missing stage are included in the total prostate cancer count but not in the subtypes.
Abbreviations: BMI, body mass index; HR, hazard ratio; NIH, National Institutes of Health; PSA, prostate specific antigen.